MITHRA PHARMACEUTICALS CDMO

Liège ·KBO/BCE: BE 0534.912.933

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	nothing on record	not filed	-
31-12-2023	31-07-2024	nothing on record	not filed	-
31-12-2022	31-07-2023	24-07-2023	7 d early	2023-00293506
31-12-2021	31-07-2022	25-07-2022	6 d early	2022-20226706
31-12-2020	31-07-2021	23-07-2021	8 d early	2021-39600311
31-12-2019	31-07-2020	13-07-2020	18 d early	2020-29200043
31-12-2018	31-07-2019	01-07-2019	30 d early	2019-29500163
31-12-2017	31-07-2018	30-07-2018	1 d early	2018-40700228
31-12-2016	31-07-2017	21-06-2017	40 d early	2017-20600460
31-12-2015	31-07-2016	22-06-2016	39 d early	2016-21900424
31-12-2014	31-07-2015	10-06-2015	51 d early	2015-16400386

Metric	This company	Sector median	Position in the sector
Solvency	-16.9%	45.8%	better than 9% of 37 sector peers
Net result	€-14.59M	€-51k	better than 9% of 37 sector peers
Equity	€-14.62M	€262k	better than 5% of 37 sector peers
Total assets	€86.42M	€2.24M	better than 87% of 37 sector peers

Line item	Code	2022
Balance sheet, Assets
TOTAL ASSETS	20/58	€86.42M
Fixed assets	21/28	€73.16M
Intangible fixed assets	21	€767k
Tangible fixed assets	22/27	€72.38M
Financial fixed assets	28	€16k
Current assets	29/58	€13.26M
Stocks & contracts in progress	3	€1.50M
Amounts receivable within one year	40/41	€10.97M
Cash & bank	54/58	€516k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€86.42M
Equity	10/15	€-14.62M
Contributions / capital	10/11	€62k
Reserves	13	€6k
Accumulated profits (losses)	14	€-19.67M
Amounts payable	17/49	€101.05M
Amounts payable after one year	17	€48.73M
Amounts payable within one year	42/48	€52.32M
Trade debts payable within one year	44	€5.34M
Income statement
Turnover	70	€26.74M
Operating result	9901	€-9.98M
Financial income	75	€406k
Financial charges	65	€5.01M
Result before taxes	9903	€-14.58M
Income taxes	67/77	€14k
Net result for the period	9904	€-14.59M
Result to be appropriated	9905	€-14.59M

Summary

NACE primary	Vervaardiging van geneesmiddelen(21201)
Legal form	Public limited company(014)
Incorporation	04-06-2013
Status	Active
Postal code	4000
First BS signal	24-06-2024
Latest BS signal	24-06-2024